Back

Spironolactone in patients with permanent atrial fibrillation, possible heart failure protective potential.

2 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Epidemiology of atrial fibrillation, miscellaneous Mechanisms for Heart Failure and Cardiac Complications ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Rafal Dabrowski

National Institute of Cardiology, Warsaw (Poland)

9 More presentations in this session

Presentation thumbnail
Associate Professor M. Dzeshka (Grodno, BY)
Abstract Slides
Presentation thumbnail
Doctor H. Kishima (Nishinomiya, JP)
Abstract Slides
Presentation thumbnail
Doctor H. Arshad (Newark, US)
Presentation thumbnail
Doctor J. Graby (Bristol, GB)
Abstract
Presentation thumbnail
Doctor K. Kadhim (Adelaide, AU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Epidemiology of atrial fibrillation, miscellaneous

The Event

Event poster

ESC Congress 2019

2 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
How to manage atrial fibrillation in heart failure
thumbnail
Congress Session
Basic science and arrhythmia pathophysiology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources